UltraV, a Bio-Medical Beauty Group, announced that it spread the latest Korean aesthetic medical technology at the International Fellowship in Advanced Aesthetic Science (IFAAS), a dermatological conference held in Sydney, Australia, on the 20th and 21st of January

At the conference, which was attended by a large number of local medical professionals, UltraV delivered academic information and know-how on UltraCol, which has been recognized worldwide for its unique technology.

In particular, in Sydney, Australia, UltraCol has been receiving a lot of interest, and the medical staff and officials who attended the event highly praised the product's safety, excellent effectiveness, and treatment know-how. 

Dr. Kwon Han Jin is a global speaker who has been giving lectures to doctors in Korea and abroad for many years and is an active academic, providing live demonstrations and medical education to doctors around the world. In particular, there are many requests for lectures from doctors from other countries, and he has been passing on his know-how on aesthetic medicine overseas.

" UltraCol is a global trend, and Korea's treatment know-how based on new medical aesthetic materials is leading the global beauty trend," said Dr. Kwon Han Jin. "In particular, Australia is one of the top 10 countries in the world in terms of demand for beauty and cosmetic procedures, and we will continue to promote the excellence of ' UltraCol through academic exchange."

             UltraCol is the first microsphere-based bio stimulator and skin booster made from FDA-registered polydioxanone (PDO) ingredients, which uses the body's immune response to stimulate autologous collagen to help with the face’s volume, lifting, and elasticity. In particular, after the treatment, it is broken down and absorbed by the body, without any adverse reactions or side-effects and no need to remove it.

             UltraCol comes in two variations, UltraCol 100 and UltraCol 200, for better results depending on the condition of the skin.

UltraCol 100 is very fine-grained and has a thin consistency, making it ideal for the under-eye area. It is effective for firming, smoothing wrinkles and strengthening collagen. Compared to 100, UltraCol 200 has coarse particles and thicker viscosity, so it can be expected to improve under-eye bags, hollow cheeks, and nasolabial folds.

In particular, it was awarded a 'IR52 Jang Yeong Sil Prize' as the first among the polymer fillers, and was recognized for its unique technology and excellent quality by obtaining the Korea Food and Drug Administration approval, European CE certification, and being selected as the Korea Outstanding Patent Award and Next Generation World Class Product for its unique patented technology.

In addition to Korea, UltraV plans to gradually expand sales in existing overseas markets such as Asia, South America, the Middle East, and Europe, as well as in new markets such as Hainan, China, and Malaysia. The company also aims to continue growing its market dominance in the local market through the differentiation strategy of UltraCol.